Cardiotoxicity of the cancer therapeutic agent imatinib mesylate
Massachusetts General Hospital · Harvard University · +5 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,164
total citations
- FWCI
- 48.57
- Percentile
- 100%
- References
- 51
Citations per year
Authors
16- RKRisto KerkeläCorresponding
- LGLuanda Grazette
Massachusetts General Hospital, Harvard University
- RYRinat Yacobi
Molecular Oncology (United States), Tufts University, Tufts Medical Center
- CICezar Iliescu
The University of Texas MD Anderson Cancer Center
- RDRichard D. Patten
Tufts University, Tufts Medical Center
Topics & keywords
Topics
Keywords
- Imatinib mesylate
- Imatinib
- Cardiotoxicity
- Endoplasmic reticulum
- Chronic myelogenous leukemia
- Cancer research
- Pharmacology
- ABL
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.